Short Interest in WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Increases By 76.7%

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totaling 1,622 shares, a growth of 76.7% from the March 31st total of 918 shares. Based on an average trading volume of 824 shares, the short-interest ratio is presently 2.0 days.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Zacks Research upgraded shares of WuXi AppTec to a “hold” rating in a report on Monday, April 13th. The Goldman Sachs Group upgraded shares of WuXi AppTec to a “buy” rating in a report on Thursday, February 5th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

WuXi AppTec Stock Performance

WUXAY opened at $15.50 on Monday. WuXi AppTec has a fifty-two week low of $7.09 and a fifty-two week high of $17.00. The company’s 50-day moving average is $15.02 and its 200 day moving average is $14.21.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.